This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Innovations by Chandrika Saidapet-Kumar
Introduction
Chandrika Saidapet-Kumar is an accomplished inventor based in West Windsor, NJ (US). She has made significant contributions to the field of therapeutic methods, particularly focusing on the C3a receptor. Her work has implications for treating inflammatory and autoimmune disorders.
Latest Patents
Chandrika holds a patent for "Therapeutic and screening methods using C3a receptor and C3a." This patent includes human C3a receptor polypeptides and DNA (RNA) encoding such C3a receptor. The patent also describes a procedure for producing these polypeptides using recombinant techniques. Furthermore, it outlines methods for utilizing the C3a receptor in the treatment of various inflammatory and autoimmune disorders. Antagonists against the C3a receptor and their therapeutic applications are also detailed. Additionally, diagnostic assays for detecting diseases related to mutations in nucleic acid sequences and altered concentrations of the polypeptides are disclosed.
Career Highlights
Chandrika is currently employed at Smithkline Beecham Corporation, where she continues to innovate and contribute to her field. Her work is characterized by a strong focus on therapeutic advancements and diagnostic methods.
Collaborations
Chandrika has collaborated with notable colleagues, including Derk J Bergsma and James J Foley. These collaborations have further enriched her research and development efforts.
Conclusion
Chandrika Saidapet-Kumar is a pioneering inventor whose work on the C3a receptor has the potential to transform therapeutic approaches for inflammatory and autoimmune disorders. Her contributions to science and medicine are invaluable and continue to inspire future innovations.